{"id":"W4412984585","doi":"10.1182/bloodadvances.2025016949","title":"Modification of belantamab mafodotin dosing to balance efficacy and tolerability in the DREAMM-7 and DREAMM-8 trials","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"GlaxoSmithKline (Canada); Princess Margaret Cancer Centre","funders":"Genentech; Servier; Regeneron Pharmaceuticals; Cilag; Astellas Pharma; Alexion Pharmaceuticals; Seagen; Gilead Sciences; BeiGene; Sanofi; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer","keywords":"Medicine; Tolerability; Adverse effect; Dosing; Photophobia; Refractory (planetary science); Internal medicine; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00107197,0.0001041806,0.0004572024,0.0001003948,0.00005580229,0.00001968317,0.00006975589,0.00004913367,0.000006802426],"category_scores_gemma":[0.0005581666,0.0000724464,0.0000308522,0.0002932992,0.0000568178,0.00007545493,0.00002875424,0.00008544148,6.918088e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000007937318,"about_ca_system_score_gemma":0.00002929204,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002911746,"about_ca_topic_score_gemma":0.00002654504,"domain_scores_codex":[0.9988661,0.0001776159,0.0004381154,0.000252157,0.0001467742,0.0001192014],"domain_scores_gemma":[0.9990501,0.0005069717,0.0001188242,0.0002365048,0.00004606128,0.00004153529],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.001417653,0.002791782,0.3033569,0.001169734,0.0002438661,0.000008623398,0.004984668,0.0001272559,0.3423616,0.05729345,0.00009962037,0.2861448],"study_design_scores_gemma":[0.006863604,0.0003887522,0.8732013,0.0006465531,0.0003655876,0.00001731758,0.0009086426,0.0002648468,0.1103015,0.005428468,0.001454439,0.0001589781],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923121,0.002517213,0.0007118863,0.002756497,0.00006724188,0.0008181116,0.000006978671,0.00002011328,0.0007898741],"genre_scores_gemma":[0.9969635,0.0003064406,0.002182124,0.0004332258,0.00003071358,0.00003136402,0.000006069864,0.000004710702,0.00004182438],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5698444,"threshold_uncertainty_score":0.2954278,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0425052666653595,"score_gpt":0.3572799157750413,"score_spread":0.3147746491096818,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}